Dimerix Limited secures A$34 million non-dilutive loan facility aimed at funding key clinical milestones. This funding enhances financial flexibility for ongoing clinical development programs.
Amount Raised
A$34 Million
Round Type
Debt Financing
MelbourneBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Dimerix Limited has successfully secured non-dilutive loan facility agreements with lenders, allowing access to A$34 million. This funding will support the company's clinical programs without diluting shareholder value. The financial flexibility is crucial for completing critical trials related to kidney disease treatments. Dimerix is dedicated to improving outcomes for patients suffering from serious kidney conditions.
Quick answer
Dimerix Limited raised A$34 Million in a Debt Financing round, dated September 4, 2026. Dimerix Limited is based in Melbourne, Victoria, Australia.
- How much did Dimerix Limited raise?
- Dimerix Limited raised A$34 Million in a Debt Financing round on September 4, 2026.
- What does Dimerix Limited do?
- Dimerix is a clinical-stage biopharmaceutical company, with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases.
- Where is Dimerix Limited based and how big is it?
- Dimerix Limited is based in Melbourne, Victoria, Australia. Fundz records about 22 employees.
- Who are the decision-makers at Dimerix Limited?
- Fundz holds 3 contacts at Dimerix Limited, including the CEO & Managing Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Dimerix Limited that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $7.2M on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
- Breye Therapeutics raised $77M (Series A) on September 29, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised $6.4M on September 8, 2026.
Who to call at Dimerix Limited, and when
A new round usually means Dimerix Limited is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Dimerix Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dimerix Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dimerix Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dimerix Limited raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dimerix Limited raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.